Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity

Bibliographic Details
Title: Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity
Authors: Xiaoyan Deng, Pierre Gantner, Julia Forestell, Amélie Pagliuzza, Elsa Brunet‐Ratnasingham, Madeleine Durand, Daniel E Kaufmann, Nicolas Chomont, Morgan Craig
Source: Clinical & Translational Immunology, Vol 12, Iss 11, Pp n/a-n/a (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: COVID‐19, plasma SARS‐CoV‐2 RNA, RAGE, SARS‐CoV‐2 kinetics, viral dynamics model, Immunologic diseases. Allergy, RC581-607
More Details: Abstract Objectives Identifying biomarkers causing differential SARS‐CoV‐2 infection kinetics associated with severe COVID‐19 is fundamental for effective diagnostics and therapeutic planning. Methods In this work, we applied mathematical modelling to investigate the relationships between patient characteristics, plasma SARS‐CoV‐2 RNA dynamics and COVID‐19 severity. Using a straightforward mathematical model of within‐host viral kinetics, we estimated key model parameters from serial plasma viral RNA (vRNA) samples from 256 hospitalised COVID‐19+ patients. Results Our model predicted that clearance rates distinguish key differences in plasma vRNA kinetics and severe COVID‐19. Moreover, our analyses revealed a strong correlation between plasma vRNA kinetics and plasma receptor for advanced glycation end products (RAGE) concentrations (a plasma biomarker of lung damage), collected in parallel to plasma vRNA from patients in our cohort, suggesting that RAGE can substitute for viral plasma shedding dynamics to prospectively classify seriously ill patients. Conclusion Overall, our study identifies factors of COVID‐19 severity, supports interventions to accelerate viral clearance and underlines the importance of mathematical modelling to better understand COVID‐19.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2050-0068
Relation: https://doaj.org/toc/2050-0068
DOI: 10.1002/cti2.1468
Access URL: https://doaj.org/article/6e0ebb221f9d41a3a15f0bdd9cf07508
Accession Number: edsdoj.6e0ebb221f9d41a3a15f0bdd9cf07508
Database: Directory of Open Access Journals
More Details
ISSN:20500068
DOI:10.1002/cti2.1468
Published in:Clinical & Translational Immunology
Language:English